Keywords: Diagnosis/Prediction, Brain
Motivation: Genetic biomarkers and WHO grading of gliomas are critical for the classification of glioma subtypes, treatment planning and survival prognosis.
Goal(s): The aim of this study is to apply DL network for non-invasive prediction of multiple genes and classification of subtypes.
Approach: A decision tree diagnostic scheme based on multi-label DL network was constructed to classify adult-type diffuse gliomas into 5 subtypes based on the 2021 WHO classification of tumor of the CNS, combining the WHO grading and 3 genetic biomarkers status.
Results: The model we developed can reclassify adult-type diffuse glioma with a diagnostic accuracy of 94.4%.
Impact: Based on the 2021 WHO CNS tumor classification, this study applies multi-label deep learning to reclassify adult-type diffuse gliomas, which can be helpful for patients to obtain preoperative diagnosis and precise treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords